Matches in Nanopublications for { ?s ?p "[Heterozygosity for a germline CHEK2 mutation appears to represent an adverse prognostic factor in patients with early-stage breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP653415.RAfV11_huHJ092UurV-EdQTwjuyYfeF-tBzHTq8saIS60130_assertion description "[Heterozygosity for a germline CHEK2 mutation appears to represent an adverse prognostic factor in patients with early-stage breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP653415.RAfV11_huHJ092UurV-EdQTwjuyYfeF-tBzHTq8saIS60130_provenance.
- assertion description "[Heterozygosity for a germline CHEK2 mutation appears to represent an adverse prognostic factor in patients with early-stage breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Heterozygosity for a germline CHEK2 mutation appears to represent an adverse prognostic factor in patients with early-stage breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP590383.RAiLYRE2SvPyP8g0bx10G6DPGXQTBNoYZPap-NEVXS9iE130_assertion description "[Heterozygosity for a germline CHEK2 mutation appears to represent an adverse prognostic factor in patients with early-stage breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP590383.RAiLYRE2SvPyP8g0bx10G6DPGXQTBNoYZPap-NEVXS9iE130_provenance.
- NP863089.RAE8GY9g2MWlHE0JFkxabL_wkakfgS_Nmm5BfNXjTczy0130_assertion description "[Heterozygosity for a germline CHEK2 mutation appears to represent an adverse prognostic factor in patients with early-stage breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP863089.RAE8GY9g2MWlHE0JFkxabL_wkakfgS_Nmm5BfNXjTczy0130_provenance.
- NP222295.RA9GLBuyEzoED6PZX3BVhjk5i0gE_J8lxekdmWFBiNvNE130_assertion description "[Heterozygosity for a germline CHEK2 mutation appears to represent an adverse prognostic factor in patients with early-stage breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP222295.RA9GLBuyEzoED6PZX3BVhjk5i0gE_J8lxekdmWFBiNvNE130_provenance.